OPEN WEBINAR

Perspectives on Quality by Design (QbD) and Process Automation Technology (PAT): pharmaceutical and other processing sectors, same challenges?

with Pascal Cavaillon (Inhalexpert), Thomas Ricour (NIR Industry),

Dr. Nicolas Mougin & Dr. Vincent Billot-Ridet (RHEONIS)

At the end of the 2000s, the Food & Drug Administration and the EMEA reacted to certain recurring difficulties in the pharmaceutical sector in the development and production of drugs, by recommending the implementation of the Quality by Design (QbD) method. , mathematical modelling, capability and Process Analytical Technologies (PAT) intended to produce critical factors in real time. This first to understand and master everything process manufacturing to then master the finished product.

Pascal Cavaillon, founder of Inhalexpert, specialist in QbD, and Thomas Ricour, founder of NIR Industry, specialist in PAT, will present these approaches and their contributions to us.

We will then look at the challenges to be met for the success of these approaches, both in pharmaceuticals and in other processing sectors.